Pulsed Electromagnetic Fields in Preventing Physical Deconditioning in Patients Undergoing Prolonged Hospitalization
Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · Dec 19, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how pulsed electromagnetic fields (PEMF) might help prevent physical decline in patients with blood cancers who are in the hospital for a long time. When patients are in the hospital and unable to move much, their bodies can weaken, which is known as physical deconditioning. The study aims to find out if PEMF can help these patients maintain their strength and mobility compared to those who do not receive this treatment. Healthy volunteers will also participate to compare the effects of PEMF on different individuals.
Eligible participants include patients undergoing chemotherapy for acute leukemia or those receiving stem cell transplants. They should be able to walk and agree to participate in physical tests and blood sample collections at the beginning, after four weeks, and after eight weeks. Patients will receive PEMF treatment twice a week for four weeks, while some may not receive any treatment at all. It’s important to note that pregnant women cannot participate, and all volunteers must be healthy without major illnesses or ongoing medical treatments. This study is currently recruiting participants and aims to learn more about how PEMF might benefit those facing long hospital stays.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Haematology patients who are undergoing induction chemotherapy for acute leukemia
- • Haematology patients who are undergoing haematopoietic stem cell transplant
- • Have ECOG 0-24. Able to walk at baseline to participate in short physical battery test.
- • For healthy volunteers, subjects have to be healthy without any major disease states, not on any drugs or requiring long term medical attention.
- Exclusion Criteria:
- • Patients who do not agree to sign the consent form.
- • Pregnant women will be excluded from the study for healthy volunteers
About National University Hospital, Singapore
National University Hospital (NUH) in Singapore is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, NUH emphasizes a multidisciplinary approach, integrating cutting-edge medical research with high-quality patient care. The hospital collaborates with various stakeholders, including academic institutions and industry partners, to explore new therapies and improve treatment outcomes across a wide range of medical disciplines. Committed to ethical standards and patient safety, NUH plays a pivotal role in shaping the future of medicine in Singapore and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kent Ridge, , Singapore
Kent Ridge, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported